This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
We have now added a new section called the "Assay History List" to the "At A Gla...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...